5. 2 días frente a 5 días de levofloxacino en la agudización de EPOC

Rodrigo García Madero

Rodrigo García Madero Medicina Interna. Hospital Universitario General de Villalbava

Palabras clave: EPOC agudizado, Antibiótico

Abstract

La duración del tratamiento antibiótico en la agudización de enfermedad pulmonar obstructiva crónica (EPOC) generalmente está basada en opinión de expertos. Habitualmente se mantiene entre 5 y 7 días. El tratamiento corto de 2 días con levofloxacino no ha sido estudiado previamente. En este ensayo aleatorizado se valora su eficacia.

Duration of antibiotic treatment in chronic obstructive pulmonary disease (COPD) exacerbation is generally based on expert opinion, usually maintaining it between 5-7 days. Short 2-day treatment with levofloxacin has not been previously studied. Its efficacy is assessed in this randomized trial.

Recibido: 06 Abril 2023
Revisión: 11 Abril 2023
Aceptado: 05 Mayo 2023

Citas

Vol 104 N10; pág. 1396-1403. 2010. Anzueto A., Miravitlles M. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD. Respiratory Medicine. doi: https://doi.org/10.1016/j.rmed.2010.05.018

Vol 94 N1; pág. 18-27. 2000. Chodosh S., DeAbate C.A., Haverstock D., et al. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Respiratory medicine. doi: https://doi.org/10.1053/rmed.1999.0708

Vol 44 N4; pág. 515-523. 1999 Langan C.E., Zuck P., Vogel F. et al. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. Journal of Antimicrob Chemotherapy. doi: https://doi.org/10.1093/jac/44.4.515

Vol 72. 2022. Llor C., Moragas A., Miravitlles M. et al. Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis. Pulmonary Pharmacology & Therapeutics. doi: https://doi.org/10.1016/j.pupt.2022.102111

Vol 25 N6; pág 1001- 1010 Martinez F.J., Grossman R.F., Zadeikis N. et al. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg. Eur Respir J 2005;25(6):1001-1010. doi: https://doi.org/10.1183/09031936.05.00106404